Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cerenetex is a private U.S. medical device and digital health company developing non-invasive diagnostic products for neurological conditions. Its lead focus is rapid detection and triage support for large vessel occlusion ischemic stroke using a passive acoustic headset and analytics platform that listens to cerebral vascular signals. Public descriptions also indicate earlier or parallel work on migraine and headache assessment. The company appears to be a small, development-stage to early commercial healthtech business headquartered in Newport Beach, California, with accelerator/incubator backing and a limited employee base. Its value proposition is faster objective neurological screening outside or ahead of imaging-intensive workflows.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cerenetex.